NorthStar marks milestone in non-uranium production of Mo-99

January 12, 2023, 12:02PMNuclear News
IBA Rhodotron TT300-HE (high energy) electron accelerator. (Photo: Business Wire)

Nuclear medicine company NorthStar Medical Radioisotopes announced that it has successfully produced molybdenum-99 at its recently completed accelerator production facility at its Beloit, Wis., campus. According to NorthStar, the event marks a major milestone in advancing the company’s proprietary electron accelerator technology for the non-uranium–based production of the critical medical radioisotope.

To continue reading, log in or create a free account!

Related Articles

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...